Scholarlink

<p>Digital therapeutics (DTx), software as a medical device, present a promising avenue for addressing the increasing burden of a range of conditions, yet their widespread implementation remains contingent upon demonstrating economic value—an understudied domain in current literature. Using a Group Concept Mapping approach, this study synthesized perspectives from healthcare professionals, researchers, industry, and public sector representatives to understand factors perceived to influence DTx economic value throughout its lifecycle. Analysis revealed 59 factors organized into eight clusters. Stakeholders consistently identified <i>DTx Impact on Patient Outcomes</i> and <i>DTx Implementation</i> as the most influential clusters affecting economic value. However, <i>DTx Associated Costs</i> and <i>DTx Monetization Models</i> clusters were reported as not receiving sufficient consideration throughout the DTx development lifecycle, particularly among researchers. Consequently, a conceptual framework of priority clusters and factors driving DTx economic value is proposed.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A group concept mapping study of stakeholder perspectives on digital therapeutics economic value drivers

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年4月10日

查看全文
  • Yoann Sapanel,
  • L. Martin Cloutier,
  • Gabriel Tremblay,
  • Anh Bourcet,
  • Florian Koerber,
  • David Lariviere,
  • Xavier Tadeo,
  • Dean Ho

摘要

Digital therapeutics (DTx), software as a medical device, present a promising avenue for addressing the increasing burden of a range of conditions, yet their widespread implementation remains contingent upon demonstrating economic value—an understudied domain in current literature. Using a Group Concept Mapping approach, this study synthesized perspectives from healthcare professionals, researchers, industry, and public sector representatives to understand factors perceived to influence DTx economic value throughout its lifecycle. Analysis revealed 59 factors organized into eight clusters. Stakeholders consistently identified DTx Impact on Patient Outcomes and DTx Implementation as the most influential clusters affecting economic value. However, DTx Associated Costs and DTx Monetization Models clusters were reported as not receiving sufficient consideration throughout the DTx development lifecycle, particularly among researchers. Consequently, a conceptual framework of priority clusters and factors driving DTx economic value is proposed.